# SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors

> **NCT07341321** · — · NOT_YET_RECRUITING · sponsor: **Medical University of Graz** · enrollment: 200 (estimated)

## Conditions studied

- mRNA Vaccination
- Hepatocellular Carcinoma
- Checkpoint Inhibitor

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07341321
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2026-07
- **Final completion:** 2026-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-01-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07341321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07341321, "SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07341321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*